Left atrial appendage closure offers promising ischaemic outcomes in patients with atrial fibrillation who refuse to take ...

Left atrial appendage occlusion might be a treatment option for patients on dialysis with atrial fibrillation.

Left atrial appendage closure (LAAC) was well tolerated and may be considered as an alternative to oral anticoagulation (OAC) ...

The data aren’t definitive, but continuing OAC or switching to another drug doesn’t seem to be enough for this high-risk ...

Medtronic (NYSE: MDT) announced today that it received CE mark approval for its Penditure LAA exclusion system.

Boston Scientific also foresees future growth in its Watchman business from a planned label expansion and concomitant ...

No benefit in terms of prevention of ischemic stroke, transient ischemic attack and cardiovascular mortality after 1 year was observed when surgical left atrial appendage occlusion was performed in ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published a comprehensive roadmap that details the use ...

Madrid, Spain – 1 September 2025: No benefit in terms of prevention of ischaemic stroke, transient ischemic attack and cardiovascular mortality after 1 year was observed when surgical left atrial ...

Atrial fibrillation (AF) is a predominant arrhythmia, posing challenges due to its association with increased morbidity, mortality, and healthcare resource ...

The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, ...